Ensemble biomarkers for guiding anti-angiogenesis therapy for ovarian cancer using deep learning
Clin Transl Med
.
2023 Jan;13(1):e1162.
doi: 10.1002/ctm2.1162.
Authors
Ching-Wei Wang
1
2
,
Yu-Ching Lee
2
,
Yi-Jia Lin
3
4
,
Chun-Chieh Chang
1
,
Aung-Kyaw-Oo Sai
1
,
Chih-Hung Wang
5
6
,
Tai-Kuang Chao
3
4
Affiliations
1
Graduate Institute of Biomedical Engineering, National Taiwan University of Science and Technology, Taipei, Taiwan.
2
Graduate Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei, Taiwan.
3
Department of Pathology, Tri-Service General Hospital, Taipei, Taiwan.
4
Institute of Pathology and Parasitology, National Defense Medical Center, Taipei, Taiwan.
5
Department of Otolaryngology-Head and Neck Surgery, Tri-Service General Hospital, Taipei, Taiwan.
6
Department of Otolaryngology-Head and Neck Surgery, National Defense Medical Center, Taipei, Taiwan.
PMID:
36639829
PMCID:
PMC9839833
DOI:
10.1002/ctm2.1162
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Biomarkers
Deep Learning*
Female
Humans
Immunotherapy
Ovarian Neoplasms* / drug therapy
Substances
Biomarkers